Falcon Genomics, Inc.

An eye on functional genomics as a tool for cancer diagnostics and therapeutics.
Home
News
The Cancer BioChip System
Officers
Presentations
Founders
Contact Us
CBCS services
Careers
Gene Expression Profiling

News Archives

  • March 13, 2007
  • Falcon Genomics, Inc. wins Phase 1 EnterPrize Business Plan Competition.http://www.pghtech.org/events/competition.asp
  • April 23, 2007
  • Falcon Genomics, Inc. wins Phase 2 EnterPrize Business Plan Competition. http://www.pghtech.org/events/competition.asp
  • August 10, 2007
  • Pittsburgh Life Science Greenhouse supports Falcon Genomics, Inc. through the Technology Development Fund (Genome Web; PRNewswire; PCQuote).
  • November 1, 2007
  • Falcon Genomics, Inc. relocates to 160 North Craig Street, Suite 222, Pittsburgh, PA 15213. 
  • February 6, 2009
  • Falcon Genomics, Inc. US patent application # 11/337,215, entitled: High-throughput assay for cancer cell growth inhibition, is allowed for issuance. 
  • February 19, 2009 
  • Falcon Genomics, Inc. co-sponsors the "6th Annual Conference on Cancer Drugs Research and Development" Philadelphia, PA.
  • Dr. Rula Abbud-Antaki presents at "6th Annual Conference on Cancer Drugs Research and Development" Philadelphia, PA. Presentation Title: The Cancer BioChip System: A tool for custon-tailored cancer diagnosis and therapy. http://www.gtcbio.com/conferenceDetails.aspx?id=143
  • May 26, 2009
  • Falcon Genomics, Inc. receives U.S. Patent # 7,537,913 with claims covering the Company's Cancer BioChip System (CBCS) for the identification and validation of potential cancer targets in a high-throughput in vitro setting with great clinical translational potential.

    http://news.prnewswire.com/ViewContent.aspx?ACCT=109&STORY=/www/story/05-28-2009/0005034230&EDATE

  • November 16, 2009
  • Dr. Rula Abbud-Antaki presents Falcon Genomics' Company Presentation at "Biotech 2009, PA Convention Center, Philadelphia, PA".
  • September 1, 2010
  • Falcon Genomics, Inc. receives Phase 1 SBIR grant from the National Cancer institute. The title of the grant is: "Development of a Test Cancer BioChip for the Cancer BioChip System", PI: Dr. Rula Abbud-Antaki.
  • September 17, 2010
  • Dr. Rula Abbud-Antaki presents at the: Emerging Company and Innovator's Showcase - Life Sciences Summit 2010, Hyatt Regency, Long Island.
  • February 17, 2010

    Dr. Rula Abbud-Antaki presents a poster titled: The Cancer BioChip System(TM): A tool for functional genomic diagnosis and cancer target identification, at the CTSA Industry Forum, NIH, Bethesda, MD.

  • October 6-7, 2011
  • Falcon Genomics, Inc. reports on the screening power of its Test Cancer BioChip in a poster titled: "Use of the Cancer Biochip System as a Tool for Identifying Therapeutic Targets in Personalizing Breast Cancer Treatment" at the Academic Screening Workshop, Bridgewater, NJ.
  • June 28, 2011
  • Dr. Rula Abbud-Antaki presents Falcon Genomics' Company Presentation at BIO 2011, Washington, DC
  • Falcon Genomics, Inc. announces opening of its gene expression profiling service.
  • December 1, 2011
  • Falcon Genomics, Inc. receives notice of allowance for its US Patent Application # 11/772,411.